Media playback is unsupported on your device

Malaria vaccine trial shows promise

8 October 2013 Last updated at 18:24 BST

A vaccine against malaria could be available in two years, following a promising medical trial carried out across seven African countries.

In 2012 there were more than 200 million cases of malaria worldwide, with more than 600,000 deaths from the disease - most in Africa where it kills one child every minute.

GlaxoSmithKline say their vaccine, which was given to some 15,000 children, reduced cases of malaria by 25% in babies under 12 weeks old, and halved the incidence in children aged from five to 17 months old.

Fergus Walsh reports.

BBC © 2014 The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.